Brendan Knapp, MD

Hometown: West Lafayette, IN
Medical School: Indiana University School of Medicine
Residency: Washington University in St. Louis/Barnes-Jewish Hospital
Research/Academic Interests: Thoracic oncology, clinical trials and outcomes research, circulating tumor DNA and genomics in non-small cell lung cancer
Bio: I have really enjoyed my 3 years in St. Louis as a resident and am looking forward to continue living here for fellowship! I love running and being active, and there are a wide variety of parks and trails in and around the city. Forest Park is my favorite part of St. Louis, and has several miles of running/biking trails, as well as an excellent (and free!) art museum, science museum, history museum, and zoo. In the summer, I love going to Shakespeare in the Park (also free) and watching shows at The Muny, an outdoor venue in the park. Tower Grove Park is another large park in the city and has a great farmer’s market during the summer months. The Katy Trail is a 200+ mile dirt trail about 20 minutes from downtown and is a great place to go for a long bike ride, and Castlewood State Park is a large state park nearby with great hiking.

St. Louis has a really great food and beer scene as well, featuring both large well-known breweries (e.g. Anheuser-Busch) and smaller craft options (my favorite is Narrow Gauge Brewing). The variety of restaurants is excellent and cost of living cannot be beat. Additionally, it is a great sports city with the Cardinals, Blues, and now a new MLS team, the St. Louis City SC. Finally, I enjoy going to art and cultural events, and St. Louis is a destination for many concerts and Broadway shows at the Fox Theatre. Overall, I have loved living here and cannot wait to explore more here the next three years.

Selected Publications/Abstracts

  • Lucas Jr JT, Knapp B, et al. Posttreatment DSC-MRI is predictive of early treatment failure in children with supratentorial high-grade glioma treated with erlotinib. Clinical neuroradiology. 2018 Sep;28(3):393-400. PubMed PMID: 28382379
  • Knapp B, et al. Exploring the Feasibility of Utilizing Limited Gene Panel Circulating Tumor DNA Clearance as a Biomarker in Patients With Locally Advanced Non-Small Cell Lung Cancer. Frontiers in oncology. 2022 Mar;12: 856132. PubMed PMID: 35419282
  • Knapp B, et al. Bone metastases in non-small cell lung cancer: a narrative review. Journal of thoracic Disease. 2022 May; 14(5): 1696-1712